A detailed history of Aspect Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aspect Partners, LLC holds 99 shares of LLY stock, worth $73,873. This represents 0.05% of its overall portfolio holdings.

Number of Shares
99
Previous 99 -0.0%
Holding current value
$73,873
Previous $89.6 Million 2.15%
% of portfolio
0.05%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $51,993 - $61,293
99 New
99 $57.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aspect Partners, LLC Portfolio

Follow Aspect Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspect Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspect Partners, LLC with notifications on news.